VBL Therapeutics to Present at 10th Annual Needham Healthcare Conference

TEL AVIV, Israel--(BUSINESS WIRE)--VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that Dror Harats, M.D., chief executive officer, will present at the 10th Annual Needham Healthcare Conference. Dr. Harats’ presentation is scheduled to begin at 10:00 a.m. EDT on Tuesday, April 5, 2011 at the New York Palace Hotel in New York City.